β-glucans from Coriolus versicolor protect mice against S. typhimurium challenge by activation of macrophages
•There are no detectable cytotoxic effects of β-glucans.•β-glucans induce strong proliferaion and expresion of CD40, CD80, and CD86 marker of macrophages.•β-glucans-treated macrophage but not itself can phagocytize and kill S. typhimurium.•β-glucans induce the production of NO and iNOS from pretreat...
Gespeichert in:
Veröffentlicht in: | International journal of biological macromolecules 2016-05, Vol.86, p.352-361 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 361 |
---|---|
container_issue | |
container_start_page | 352 |
container_title | International journal of biological macromolecules |
container_volume | 86 |
creator | Shi, Shao-Hua Yang, Wen-Tao Huang, Ke-Yan Jiang, Yan-Long Yang, Gui-Lian Wang, Chun-Feng Li, Yu |
description | •There are no detectable cytotoxic effects of β-glucans.•β-glucans induce strong proliferaion and expresion of CD40, CD80, and CD86 marker of macrophages.•β-glucans-treated macrophage but not itself can phagocytize and kill S. typhimurium.•β-glucans induce the production of NO and iNOS from pretreated macrophages.•β-glucans-treated macrophages are effective at protecting mice against the challenge of S. typhimurium.
The effects of β-glucans from Coriolus versicolor (CVP), which are extracted from a well-known immune stimulator C. versicolor, have been demonstrated extensively in vitro and in vivo. However, until now, the phagocytic activity has not been elucidated. Hence, the objective of the present study was to identify the antibacterial activity of CVP or CVP-treated macrophages by an analysis of cell cytotoxicity, phagocytic activity, intracellular bacterial survival, macrophage activation, production of nitric oxide (NO) and expression of inducible nitric oxide synthase (iNOS) in CVP-treated macrophages using flow cytometry, RT-PCR, a gentamicin protection assay, a Nitric oxide assay and an iNOS enzymatic activity assay. The results indicate that CVP-treated macrophages can phagocytize and kill bacteria, probably due to the production of NO and iNOS. More importantly, CVP-treated macrophages are effective at protecting mice against the challenge of Salmonella typhimurium. The results of this study suggest that the antibacterial effects of CVP are probably caused by the activation of innate immune cells, especially macrophages, because the activated macrophage produces NO, which kills bacteria. These phenomena indicate the possibility of CVP as a potential alternative for antibiotics against resistant bacteria. |
doi_str_mv | 10.1016/j.ijbiomac.2016.01.058 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1776093351</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0141813016300605</els_id><sourcerecordid>1776093351</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-376de6a85e9b99c7ef3121f23ad49e7cbcc5dae1fbb967ba00879e60b1d9f5333</originalsourceid><addsrcrecordid>eNqFkE1OwzAQhS0EoqVwhcpLNgmeuHGSHajiT0JiAawt25m0rpK42EmlXouDcCaMCmxZjWb0Zua9j5A5sBQYiKtNajfauk6ZNIt9yiBleXlEplAWVcIY48dkymABSQmcTchZCJs4FTmUp2SSiZJl2WIxJf3nR7JqR6P6QBvvOrp03rp2DHSHPljjWufp1rsBzUA7a5CqlbJ9GOhLSof9dm270duxo2at2hb7FVK9p8oMdqcG63rqGhpNerddqxWGc3LSqDbgxU-dkbe729flQ_L0fP-4vHlKDBflkPBC1ChUmWOlq8oU2HDIoMm4qhcVFkYbk9cKodG6EoVWjMXUKJiGumpyzvmMXB7uRuvvI4ZBdjYYbFvVoxuDhKIQrOI8hygVB2k0GYLHRm697ZTfS2Dym7XcyF_W8pu1ZCAj67g4__kx6g7rv7VfuFFwfRBgTLqz6GUwFnuDtfURp6yd_e_HF-W7lsc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1776093351</pqid></control><display><type>article</type><title>β-glucans from Coriolus versicolor protect mice against S. typhimurium challenge by activation of macrophages</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Shi, Shao-Hua ; Yang, Wen-Tao ; Huang, Ke-Yan ; Jiang, Yan-Long ; Yang, Gui-Lian ; Wang, Chun-Feng ; Li, Yu</creator><creatorcontrib>Shi, Shao-Hua ; Yang, Wen-Tao ; Huang, Ke-Yan ; Jiang, Yan-Long ; Yang, Gui-Lian ; Wang, Chun-Feng ; Li, Yu</creatorcontrib><description>•There are no detectable cytotoxic effects of β-glucans.•β-glucans induce strong proliferaion and expresion of CD40, CD80, and CD86 marker of macrophages.•β-glucans-treated macrophage but not itself can phagocytize and kill S. typhimurium.•β-glucans induce the production of NO and iNOS from pretreated macrophages.•β-glucans-treated macrophages are effective at protecting mice against the challenge of S. typhimurium.
The effects of β-glucans from Coriolus versicolor (CVP), which are extracted from a well-known immune stimulator C. versicolor, have been demonstrated extensively in vitro and in vivo. However, until now, the phagocytic activity has not been elucidated. Hence, the objective of the present study was to identify the antibacterial activity of CVP or CVP-treated macrophages by an analysis of cell cytotoxicity, phagocytic activity, intracellular bacterial survival, macrophage activation, production of nitric oxide (NO) and expression of inducible nitric oxide synthase (iNOS) in CVP-treated macrophages using flow cytometry, RT-PCR, a gentamicin protection assay, a Nitric oxide assay and an iNOS enzymatic activity assay. The results indicate that CVP-treated macrophages can phagocytize and kill bacteria, probably due to the production of NO and iNOS. More importantly, CVP-treated macrophages are effective at protecting mice against the challenge of Salmonella typhimurium. The results of this study suggest that the antibacterial effects of CVP are probably caused by the activation of innate immune cells, especially macrophages, because the activated macrophage produces NO, which kills bacteria. These phenomena indicate the possibility of CVP as a potential alternative for antibiotics against resistant bacteria.</description><identifier>ISSN: 0141-8130</identifier><identifier>EISSN: 1879-0003</identifier><identifier>DOI: 10.1016/j.ijbiomac.2016.01.058</identifier><identifier>PMID: 26802244</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adjuvants, Immunologic - isolation & purification ; Adjuvants, Immunologic - pharmacology ; Animals ; Antibacterial activities ; beta-Glucans - isolation & purification ; beta-Glucans - pharmacology ; Body Weight - drug effects ; Coriolus versicolor ; Female ; Gene Expression Regulation, Enzymologic - drug effects ; Intracellular Space - drug effects ; Intracellular Space - microbiology ; Macrophage Activation - drug effects ; Macrophages ; Macrophages - cytology ; Macrophages - drug effects ; Macrophages - immunology ; Macrophages - metabolism ; Mice ; Nitric Oxide - biosynthesis ; Nitric Oxide Synthase Type II - genetics ; Nitric Oxide Synthase Type II - metabolism ; Phagocytosis - drug effects ; Polyporaceae - chemistry ; RAW 264.7 Cells ; Salmonella typhimurium ; Salmonella typhimurium - drug effects ; Salmonella typhimurium - growth & development ; Salmonella typhimurium - physiology ; β-glucans</subject><ispartof>International journal of biological macromolecules, 2016-05, Vol.86, p.352-361</ispartof><rights>2016 Elsevier B.V.</rights><rights>Copyright © 2016 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-376de6a85e9b99c7ef3121f23ad49e7cbcc5dae1fbb967ba00879e60b1d9f5333</citedby><cites>FETCH-LOGICAL-c368t-376de6a85e9b99c7ef3121f23ad49e7cbcc5dae1fbb967ba00879e60b1d9f5333</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0141813016300605$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26802244$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shi, Shao-Hua</creatorcontrib><creatorcontrib>Yang, Wen-Tao</creatorcontrib><creatorcontrib>Huang, Ke-Yan</creatorcontrib><creatorcontrib>Jiang, Yan-Long</creatorcontrib><creatorcontrib>Yang, Gui-Lian</creatorcontrib><creatorcontrib>Wang, Chun-Feng</creatorcontrib><creatorcontrib>Li, Yu</creatorcontrib><title>β-glucans from Coriolus versicolor protect mice against S. typhimurium challenge by activation of macrophages</title><title>International journal of biological macromolecules</title><addtitle>Int J Biol Macromol</addtitle><description>•There are no detectable cytotoxic effects of β-glucans.•β-glucans induce strong proliferaion and expresion of CD40, CD80, and CD86 marker of macrophages.•β-glucans-treated macrophage but not itself can phagocytize and kill S. typhimurium.•β-glucans induce the production of NO and iNOS from pretreated macrophages.•β-glucans-treated macrophages are effective at protecting mice against the challenge of S. typhimurium.
The effects of β-glucans from Coriolus versicolor (CVP), which are extracted from a well-known immune stimulator C. versicolor, have been demonstrated extensively in vitro and in vivo. However, until now, the phagocytic activity has not been elucidated. Hence, the objective of the present study was to identify the antibacterial activity of CVP or CVP-treated macrophages by an analysis of cell cytotoxicity, phagocytic activity, intracellular bacterial survival, macrophage activation, production of nitric oxide (NO) and expression of inducible nitric oxide synthase (iNOS) in CVP-treated macrophages using flow cytometry, RT-PCR, a gentamicin protection assay, a Nitric oxide assay and an iNOS enzymatic activity assay. The results indicate that CVP-treated macrophages can phagocytize and kill bacteria, probably due to the production of NO and iNOS. More importantly, CVP-treated macrophages are effective at protecting mice against the challenge of Salmonella typhimurium. The results of this study suggest that the antibacterial effects of CVP are probably caused by the activation of innate immune cells, especially macrophages, because the activated macrophage produces NO, which kills bacteria. These phenomena indicate the possibility of CVP as a potential alternative for antibiotics against resistant bacteria.</description><subject>Adjuvants, Immunologic - isolation & purification</subject><subject>Adjuvants, Immunologic - pharmacology</subject><subject>Animals</subject><subject>Antibacterial activities</subject><subject>beta-Glucans - isolation & purification</subject><subject>beta-Glucans - pharmacology</subject><subject>Body Weight - drug effects</subject><subject>Coriolus versicolor</subject><subject>Female</subject><subject>Gene Expression Regulation, Enzymologic - drug effects</subject><subject>Intracellular Space - drug effects</subject><subject>Intracellular Space - microbiology</subject><subject>Macrophage Activation - drug effects</subject><subject>Macrophages</subject><subject>Macrophages - cytology</subject><subject>Macrophages - drug effects</subject><subject>Macrophages - immunology</subject><subject>Macrophages - metabolism</subject><subject>Mice</subject><subject>Nitric Oxide - biosynthesis</subject><subject>Nitric Oxide Synthase Type II - genetics</subject><subject>Nitric Oxide Synthase Type II - metabolism</subject><subject>Phagocytosis - drug effects</subject><subject>Polyporaceae - chemistry</subject><subject>RAW 264.7 Cells</subject><subject>Salmonella typhimurium</subject><subject>Salmonella typhimurium - drug effects</subject><subject>Salmonella typhimurium - growth & development</subject><subject>Salmonella typhimurium - physiology</subject><subject>β-glucans</subject><issn>0141-8130</issn><issn>1879-0003</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1OwzAQhS0EoqVwhcpLNgmeuHGSHajiT0JiAawt25m0rpK42EmlXouDcCaMCmxZjWb0Zua9j5A5sBQYiKtNajfauk6ZNIt9yiBleXlEplAWVcIY48dkymABSQmcTchZCJs4FTmUp2SSiZJl2WIxJf3nR7JqR6P6QBvvOrp03rp2DHSHPljjWufp1rsBzUA7a5CqlbJ9GOhLSof9dm270duxo2at2hb7FVK9p8oMdqcG63rqGhpNerddqxWGc3LSqDbgxU-dkbe729flQ_L0fP-4vHlKDBflkPBC1ChUmWOlq8oU2HDIoMm4qhcVFkYbk9cKodG6EoVWjMXUKJiGumpyzvmMXB7uRuvvI4ZBdjYYbFvVoxuDhKIQrOI8hygVB2k0GYLHRm697ZTfS2Dym7XcyF_W8pu1ZCAj67g4__kx6g7rv7VfuFFwfRBgTLqz6GUwFnuDtfURp6yd_e_HF-W7lsc</recordid><startdate>201605</startdate><enddate>201605</enddate><creator>Shi, Shao-Hua</creator><creator>Yang, Wen-Tao</creator><creator>Huang, Ke-Yan</creator><creator>Jiang, Yan-Long</creator><creator>Yang, Gui-Lian</creator><creator>Wang, Chun-Feng</creator><creator>Li, Yu</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201605</creationdate><title>β-glucans from Coriolus versicolor protect mice against S. typhimurium challenge by activation of macrophages</title><author>Shi, Shao-Hua ; Yang, Wen-Tao ; Huang, Ke-Yan ; Jiang, Yan-Long ; Yang, Gui-Lian ; Wang, Chun-Feng ; Li, Yu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-376de6a85e9b99c7ef3121f23ad49e7cbcc5dae1fbb967ba00879e60b1d9f5333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adjuvants, Immunologic - isolation & purification</topic><topic>Adjuvants, Immunologic - pharmacology</topic><topic>Animals</topic><topic>Antibacterial activities</topic><topic>beta-Glucans - isolation & purification</topic><topic>beta-Glucans - pharmacology</topic><topic>Body Weight - drug effects</topic><topic>Coriolus versicolor</topic><topic>Female</topic><topic>Gene Expression Regulation, Enzymologic - drug effects</topic><topic>Intracellular Space - drug effects</topic><topic>Intracellular Space - microbiology</topic><topic>Macrophage Activation - drug effects</topic><topic>Macrophages</topic><topic>Macrophages - cytology</topic><topic>Macrophages - drug effects</topic><topic>Macrophages - immunology</topic><topic>Macrophages - metabolism</topic><topic>Mice</topic><topic>Nitric Oxide - biosynthesis</topic><topic>Nitric Oxide Synthase Type II - genetics</topic><topic>Nitric Oxide Synthase Type II - metabolism</topic><topic>Phagocytosis - drug effects</topic><topic>Polyporaceae - chemistry</topic><topic>RAW 264.7 Cells</topic><topic>Salmonella typhimurium</topic><topic>Salmonella typhimurium - drug effects</topic><topic>Salmonella typhimurium - growth & development</topic><topic>Salmonella typhimurium - physiology</topic><topic>β-glucans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shi, Shao-Hua</creatorcontrib><creatorcontrib>Yang, Wen-Tao</creatorcontrib><creatorcontrib>Huang, Ke-Yan</creatorcontrib><creatorcontrib>Jiang, Yan-Long</creatorcontrib><creatorcontrib>Yang, Gui-Lian</creatorcontrib><creatorcontrib>Wang, Chun-Feng</creatorcontrib><creatorcontrib>Li, Yu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of biological macromolecules</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shi, Shao-Hua</au><au>Yang, Wen-Tao</au><au>Huang, Ke-Yan</au><au>Jiang, Yan-Long</au><au>Yang, Gui-Lian</au><au>Wang, Chun-Feng</au><au>Li, Yu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>β-glucans from Coriolus versicolor protect mice against S. typhimurium challenge by activation of macrophages</atitle><jtitle>International journal of biological macromolecules</jtitle><addtitle>Int J Biol Macromol</addtitle><date>2016-05</date><risdate>2016</risdate><volume>86</volume><spage>352</spage><epage>361</epage><pages>352-361</pages><issn>0141-8130</issn><eissn>1879-0003</eissn><abstract>•There are no detectable cytotoxic effects of β-glucans.•β-glucans induce strong proliferaion and expresion of CD40, CD80, and CD86 marker of macrophages.•β-glucans-treated macrophage but not itself can phagocytize and kill S. typhimurium.•β-glucans induce the production of NO and iNOS from pretreated macrophages.•β-glucans-treated macrophages are effective at protecting mice against the challenge of S. typhimurium.
The effects of β-glucans from Coriolus versicolor (CVP), which are extracted from a well-known immune stimulator C. versicolor, have been demonstrated extensively in vitro and in vivo. However, until now, the phagocytic activity has not been elucidated. Hence, the objective of the present study was to identify the antibacterial activity of CVP or CVP-treated macrophages by an analysis of cell cytotoxicity, phagocytic activity, intracellular bacterial survival, macrophage activation, production of nitric oxide (NO) and expression of inducible nitric oxide synthase (iNOS) in CVP-treated macrophages using flow cytometry, RT-PCR, a gentamicin protection assay, a Nitric oxide assay and an iNOS enzymatic activity assay. The results indicate that CVP-treated macrophages can phagocytize and kill bacteria, probably due to the production of NO and iNOS. More importantly, CVP-treated macrophages are effective at protecting mice against the challenge of Salmonella typhimurium. The results of this study suggest that the antibacterial effects of CVP are probably caused by the activation of innate immune cells, especially macrophages, because the activated macrophage produces NO, which kills bacteria. These phenomena indicate the possibility of CVP as a potential alternative for antibiotics against resistant bacteria.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>26802244</pmid><doi>10.1016/j.ijbiomac.2016.01.058</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0141-8130 |
ispartof | International journal of biological macromolecules, 2016-05, Vol.86, p.352-361 |
issn | 0141-8130 1879-0003 |
language | eng |
recordid | cdi_proquest_miscellaneous_1776093351 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adjuvants, Immunologic - isolation & purification Adjuvants, Immunologic - pharmacology Animals Antibacterial activities beta-Glucans - isolation & purification beta-Glucans - pharmacology Body Weight - drug effects Coriolus versicolor Female Gene Expression Regulation, Enzymologic - drug effects Intracellular Space - drug effects Intracellular Space - microbiology Macrophage Activation - drug effects Macrophages Macrophages - cytology Macrophages - drug effects Macrophages - immunology Macrophages - metabolism Mice Nitric Oxide - biosynthesis Nitric Oxide Synthase Type II - genetics Nitric Oxide Synthase Type II - metabolism Phagocytosis - drug effects Polyporaceae - chemistry RAW 264.7 Cells Salmonella typhimurium Salmonella typhimurium - drug effects Salmonella typhimurium - growth & development Salmonella typhimurium - physiology β-glucans |
title | β-glucans from Coriolus versicolor protect mice against S. typhimurium challenge by activation of macrophages |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T15%3A58%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%CE%B2-glucans%20from%20Coriolus%20versicolor%20protect%20mice%20against%20S.%20typhimurium%20challenge%20by%20activation%20of%20macrophages&rft.jtitle=International%20journal%20of%20biological%20macromolecules&rft.au=Shi,%20Shao-Hua&rft.date=2016-05&rft.volume=86&rft.spage=352&rft.epage=361&rft.pages=352-361&rft.issn=0141-8130&rft.eissn=1879-0003&rft_id=info:doi/10.1016/j.ijbiomac.2016.01.058&rft_dat=%3Cproquest_cross%3E1776093351%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1776093351&rft_id=info:pmid/26802244&rft_els_id=S0141813016300605&rfr_iscdi=true |